# Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

> **NCT00489515** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 115 (actual)

## Conditions studied

- Colorectal Cancer
- Gallbladder Cancer
- Gastric Cancer
- Pancreatic Cancer
- Small Intestine Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00489515
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 2009-06
- **Final completion:** 2010-08
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489515, "Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00489515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*